DOD Biotech PCL Stock

DOD Biotech PCL EBIT per Employee

The EBIT per Employee of DOD Biotech PCL (DOD.BK) as of Aug 3, 2026 is 94,719.06 THB. In the previous year, EBIT per Employee was 152,078.42 THB — a change of -37.72% (lower).

EBIT per Employee

94,719.06THB

YoY

-37.72%

Last updated:

EBIT per Employee of DOD Biotech PCL is 2026 94,719.06 THB. EBIT per Employee of DOD Biotech PCL was 2025 152,078.42 THB. It decreases by -37.72% lower compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

DOD Biotech PCL Stock analysis

What does DOD Biotech PCL do? DOD Biotech PCL is a Thai biotechnology company specializing in the production of pharmaceuticals, diagnostics, and research products. Established in 2004, the company has become one of the most reputable biotechnology companies in Thailand. Its business model is based on the development and manufacturing of products used in medicine, veterinary medicine, and research. DOD Biotech PLC focuses on continually evolving and adapting its products to meet customer needs. Its main areas of focus are the production of pharmaceuticals, particularly anti-cancer drugs, diabetes medications, cardiovascular medications, and infection treatments. Additionally, the company manufactures diagnostics for disease early detection and precise diagnosis. It also offers a variety of products for research purposes. DOD Biotech PCL has partnerships with several companies in other countries, particularly in Asia and Europe. Its largest partner is the Indian company Sun Pharma, with which it has had a successful collaboration for many years. The company is known for its high-quality standards and is certified to ISO 9001:2015 and follows the Good Manufacturing Practices (GMP) required by the Thai FDA. DOD Biotech PCL has received international recognition, including the Frost & Sullivan Thailand Excellence Award and being recognized as a top 30 company in Thailand in 2020. Over the years, the company has built a loyal customer base that appreciates its high-quality products and excellent customer service. It has a strong online presence to better reach and serve its customers. In summary, DOD Biotech PCL is a leading biotechnology company in Thailand with a wide range of pharmaceuticals, diagnostics, and research products. It has earned an excellent reputation for its high-quality standards and top-notch customer service. With its strong online presence and partnerships with other companies in Asia and Europe, DOD Biotech PCL will undoubtedly remain an important player in the global healthcare market in the future. DOD Biotech PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DOD Biotech PCL stock

EBIT per Employee of DOD Biotech PCL is 94,719.06 THB in 2026.

EBIT per Employee of DOD Biotech PCL changed from 152,078.42 THB to 94,719.06 THB, representing a -37.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee DOD Biotech PCL since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's THB is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's DOD Biotech PCL historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Workforce — DOD Biotech PCL

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — DOD Biotech PCL